New strategy aims to stop HIV in its tracks for thousands of women
NCT ID NCT06743204
Summary
This study aims to see if adding testing for common sexually transmitted infections (STIs) to standard HIV prevention screening helps more young women in Africa start and continue taking PrEP, a daily pill that prevents HIV. About 4,500 women in Uganda will be randomly assigned to receive either the standard screening or the standard screening plus STI tests. Researchers will track how many women begin PrEP and how consistently they take it over six months to see if the extra testing makes a difference.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Rakai Health Sciences Program
RECRUITINGKalisizo, Uganda
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.